Search results
Author(s):
Antoni Martínez-Rubio
,
Gheorghe-Andrei Dan
Added:
3 years ago
Are low doses of direct-acting oral anticoagulants justified and appropriate in patients with nonvalvular atrial fibrillation?
The novel direct-acting oral anticoagulants (NOACs) apixaban, dabigatran, edoxaban and rivaroxaban overcome most drawbacks of vitamin K antagonists and have proven efficacious and safe in well-designed multicentre randomised clinical trials.1–4 Furthermore, the…
View more
Author(s):
Emmanuel Sorbets
,
Philippe Gabriel Steg
Added:
3 years ago
Despite improvements in the management of coronary artery disease over the last decades, ischaemic heart disease remains the leading cause of mortality worldwide and the leading cause of premature death.1,2 Patients with chronic coronary syndromes (CCS) encompass a heterogeneous population, including those with demonstrable coronary artery disease by anatomical testing or evidence of ischaemia,…
View more
Antoni Martínez-Rubio
Research Area(s) / Expertise:
Author
Author(s):
Antoni Martínez-Rubio
,
Mario DiazNuila-Alcazar
,
Anna Soria Cadena
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice in Western countries. The prevalence of AF depends on the population studied1 and especially on age.2–9 It is affected by increasing longevity and is modulated by the prevalence of cardiovascular risk factors, especially arterial hypertension and related habits. In Spain, for example, the prevalence of AF…
View more
Author(s):
Manesh R Patel
Added:
1 year ago
In this short interview from our coverage of ACC.22 late-breaking trials, Dr Manesh Patel (Duke Heart Center, US) discusses the multicentre, randomised, double-blind PACIFIC-AF trial (Bayer)(NCT04218266).
The trial sought to determine the efficacy of the oral FXIa inhibitor asundexian and evaluate the safety of the drug, compared to the non-vitamin K oral anticoagulant (NOAC) apixaban, in…
View more
Author(s):
Román Freixa Pamias
,
Pere Blanch Gràcia
,
Lluïsa Rodriguez Latre
,
et al
Added:
3 years ago
Best Poster Award
Topic: 1. Clinical Cardiology
Introduction and Objectives
Conventional care model between cardiology and primary care has many limitations (i.e. inadequate communication and coordination between healthcare levels). A change in healthcare model is mandatory. The objective of this study is to analyze the impact of implementing a program integrating cardiology and primary care…
View more
Author(s):
Grace Shu-wen Chang
,
Doreen Su-Yin Tan
Added:
3 years ago
Warfarin is a widely used anticoagulant for the prevention and treatment of thromboembolic disorders. It is well known that there is considerable inter-individual variability in warfarin dose requirements. Furthermore, because warfarin has a narrow therapeutic window, there is a risk of serious sequelae, such as thromboembolism or bleeding, if international normalised ratio (INR) levels fall into…
View more
Author(s):
Ana Pardo Sanz
,
Jose Luis Zamorano
Added:
3 years ago
Search Strategy
An independent literature search was performed on the topic ‘AF in cancer patients’ with the assistance of professional librarians. The search terms included anticoagulation, cancer, cardioncology, vitamin K antagonist, direct oral anticoagulants, bleeding risk and embolic risk. An electronic search was conducted using a minimum of two major databases (Cochrane Registry, MEDLINE)…
View more
Author(s):
Antoni Martínez-Rubio
,
Soledad Ascoeta
,
Fadwa Taibi
,
et al
Added:
3 years ago
In the last months of 2019 and the beginning of 2020, a novel disease appeared, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a very contagious virus, which causes coronavirus disease 2019 (COVID-19). The clinical manifestations of this virus in humans vary widely from asymptomatic to severe, with diverse symptomatology and even death. The substantial transmission from…
View more
Author(s):
Zaki Akhtar
,
Lisa WM Leung
,
Christos Kontogiannis
,
et al
Added:
2 years ago